Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00102115 · ClinicalTrials.gov registry record · Phase 1
Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular Disease
A Phase 1 study, sponsored by Light Sciences.
- Terminated
- Registry status
- Phase 1
- Development phase
- 27
- Enrollment target
NCT00102115: Clinical Trial Phase 1 study, sponsored by Light Sciences.
NCT00102115 is a Phase 1 study that was terminated before completion, run by Light Sciences. The registered enrollment target is 27 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00102115, a Phase 1 study, was terminated before completion, sponsored by Light Sciences.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 27 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and tolerability of Talaporfin Sodium (LS11) Photodynamic Therapy in patients with late stage Age-Related Macular Disease (AMD).
Interventions
- DRUG Talaporfin Sodium (LS11) Photodynamic Therapy (PDT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2004-12 |
| Est. Completion | 2006-01 |
| Phase | Phase 1 |
Why NCT00102115 stopped before completion
NCT00102115 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (55% lower).
The record links to 0 conditions, and to 1 intervention - of which Talaporfin Sodium (LS11) Photodynamic Therapy (PDT) is the first listed.
NCT00102115 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00102115 about?
NCT00102115 is a clinical study titled "Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular Disease". The purpose of this study is to determine the safety and tolerability of Talaporfin Sodium (LS11) Photodynamic Therapy in patients with late stage Age-Related Macular Disease (AMD).
What is the current status of trial NCT00102115?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2004-12. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00102115?
The interventions under investigation include: Talaporfin Sodium (LS11) Photodynamic Therapy (PDT) (DRUG).
Who is sponsoring clinical trial NCT00102115?
This trial is sponsored by Light Sciences, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00102115's enrollment target sits among peer trials
27 1463rd of 2000 higher than 519 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia